DecemberSTROKE PREVENTION IN ATRIAL FIBRILLATION: ROLE OF THE NEWER ORAL ANTICOAGULANTS

First Page		Document Content
Date: 2014-12-05 13:08:19 Anticoagulants Coagulation system Direct thrombin inhibitors Amides Dabigatran Warfarin Apixaban Rivaroxaban Stroke Chemistry Organic chemistry Hematology		DecemberSTROKE PREVENTION IN ATRIAL FIBRILLATION: ROLE OF THE NEWER ORAL ANTICOAGULANTS Add to Reading List Source URL: www.medicalpharmacies.com Download Document from Source Website File Size: 367,45 KB Share Document on Facebook

	* Drug Safety Alert * Xarelto (Rivaroxaban) Tablets FDA MedWatch - August 2013 Safety Labeling Changes with revisions to Prescribing Information [PostedThe MedWatch August 2013 Safety Labeling Changes po DocID: 1t7rk - View Document
	Microsoft Word - frommtg draft uspi xarelto rivaroxaban.doc DocID: 1sPZ1 - View Document
	MEDICATION GUIDE XARELTO® (zah-REL-toe) (rivaroxaban) tablets Read this Medication Guide before you start taking XARELTO and each time you get a refill. There may be new information. This Medication Guide does not take DocID: 1scq8 - View Document
	Atrial Fibrillation (AFib) Treatment Adherence Following your treatment plan will reduce your risk of AFib-related stroke. it can enter the bloodstream and cause a stroke. A stroke means DocID: 1pjDF - View Document
	QuarterWatch Monitoring FDA MedWatch Reports Why Reports of Serious Adverse Drug Events Continue to Grow October 3, 2012 Data from 2012 Quarter 1 DocID: 1p1ui - View Document